BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9734973)

  • 1. Valvular heart disease and Chinese-herb nephropathy.
    Van Ypersele de Strihou C
    Lancet; 1998 Mar; 351(9107):991; author reply 991-2. PubMed ID: 9734973
    [No Abstract]   [Full Text] [Related]  

  • 2. Valvular heart disease and Chinese-herb nephropathy.
    Ono T; Eri M; Honda G; Kuwahara T
    Lancet; 1998 Mar; 351(9107):991-2. PubMed ID: 9734974
    [No Abstract]   [Full Text] [Related]  

  • 3. Association of valvular heart disease with Chinese-herb nephropathy.
    Vanherweghem JL
    Lancet; 1997 Dec 20-27; 350(9094):1858. PubMed ID: 9428286
    [No Abstract]   [Full Text] [Related]  

  • 4. High prevalence of fenfluramine-related aortic regurgitation in women with end-stage renal disease secondary to Chinese herb nephropathy.
    Unger P; Nortier J; Muniz Martinez MC; Plein D; Vandenbossche JL; Vereerstraeten P; Vanherweghem JL
    Nephrol Dial Transplant; 2003 May; 18(5):906-10. PubMed ID: 12686663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chinese herb nephropathy is not a (dex)fenfluramine nephropathy but a serotonin nephropathy.
    Malak J
    J Altern Complement Med; 1998; 4(2):131-2. PubMed ID: 9628201
    [No Abstract]   [Full Text] [Related]  

  • 6. A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation.
    Jick H; Vasilakis C; Weinrauch LA; Meier CR; Jick SS; Derby LE
    N Engl J Med; 1998 Sep; 339(11):719-24. PubMed ID: 9731087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recall of slimming agents fenfluramine and dexfenfluramine--for what reason?].
    Jensen K
    Ugeskr Laeger; 1998 Aug; 160(36):5217. PubMed ID: 9741291
    [No Abstract]   [Full Text] [Related]  

  • 8. [Valvular regurgitation caused by anorectic agents].
    Melero Tejedor JM; Rodríguez Bailón I; Such Martínez M; Porras Martín C; Olalla Mercadé E; Espinosa Caliani JS
    Rev Esp Cardiol; 2000 Dec; 53(12):1667-70. PubMed ID: 11171493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How can benfluorex-related heart valve disease be identified by echocardiography?
    Tribouilloy C; Rusinaru D; Andréjak M
    Arch Cardiovasc Dis; 2011 Oct; 104(10):489-92. PubMed ID: 22044700
    [No Abstract]   [Full Text] [Related]  

  • 10. Benfluorex and valvular heart disease: a cohort study of a million people with diabetes mellitus.
    Weill A; Païta M; Tuppin P; Fagot JP; Neumann A; Simon D; Ricordeau P; Montastruc JL; Allemand H
    Pharmacoepidemiol Drug Saf; 2010 Dec; 19(12):1256-62. PubMed ID: 20945504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced valve disease and considerations of benefit versus risk.
    Borer JS
    Eur Heart J; 2013 Dec; 34(46):3535-7. PubMed ID: 24042062
    [No Abstract]   [Full Text] [Related]  

  • 12. [Nephrotoxic and cancer risk of Chinese plant anorectics].
    Stepánek J
    Cas Lek Cesk; 2010; 149(3):137-8. PubMed ID: 20429352
    [No Abstract]   [Full Text] [Related]  

  • 13. Benfluorex: lesions on a bioprosthetic heart valve too.
    Prescrire Int; 2012 Oct; 21(131):240-1. PubMed ID: 23189378
    [No Abstract]   [Full Text] [Related]  

  • 14. [Appetite suppressants and heart valve disorders].
    Adams C; Cohen A
    Arch Mal Coeur Vaiss; 1999 Sep; 92(9):1213-9. PubMed ID: 10533670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of fenfluramine-derivative diet pills on cardiac valves: a meta-analysis of observational studies.
    Sachdev M; Miller WC; Ryan T; Jollis JG
    Am Heart J; 2002 Dec; 144(6):1065-73. PubMed ID: 12486432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fen-phen and risk of valvular disease.
    SoRelle R
    Circulation; 1997 Sep; 96(6):1705-6. PubMed ID: 9323046
    [No Abstract]   [Full Text] [Related]  

  • 17. Frequency of drug-induced valvular heart disease in patients previously exposd to benfluorex: a multicentre prospective study.
    Tribouilloy C; Maréchaux S; Jobic Y; Jeu A; Ederhy S; Donal E; Réant P; Arnalsteen E; Boulanger J; Garban T; Ennezat PV; Andréjak M; Rusinaru D
    Eur Heart J; 2013 Dec; 34(46):3580-7. PubMed ID: 24014218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [About the settlement of litigations concerning the harm caused by benfluorex (Mediator®)].
    Nicot P; Frachon I; Hill C
    Presse Med; 2013 Apr; 42(4 Pt 1):411-8. PubMed ID: 23490638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Letter on the article: "benfluorex and valvular heart disease"].
    Jobic Y; Etienne Y; Tribouilloy C; Bruneval P; Frachon I
    Presse Med; 2012 Mar; 41(3 Pt 1):326-7. PubMed ID: 22317843
    [No Abstract]   [Full Text] [Related]  

  • 20. Anorectic drugs and valvular heart disease.
    Krynicki PF
    Cleve Clin J Med; 1998 May; 65(5):277; author reply 277-8. PubMed ID: 9599914
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.